Surgery News and Research

RSS

Transvaginal ultrasound effective in treating early-stage endometrial cancer

A common birth control device is effective in treating early-stage endometrial cancer in morbidly obese and high-risk surgery patients, said Georgia Health Sciences University Cancer Center researchers, and could lead to a cost-effective treatment for all women with this cancer type.

17 Oct 2012

Brachyury variation may increase risk of chordoma

A genetic variation possessed by 40% of the population is associated with a five-fold increase in risk for developing chordoma, a cancer that strikes the bones of the skull and spine.

17 Oct 2012

Antibiotic injections are associated with lower risk of infection in cataract surgery

Intracameral antibiotic injections were associated with a 22-fold reduction in the risk of postoperative infection following cataract surgery when compared with the standard post-operative treatment of antibiotic eyedrops, according to a Kaiser Permanente study.

16 Oct 2012

Widening treatment options for parotid duct stenoses

Parotidectomy should no longer be regarded as a routine treatment for parotid duct stenosis and should be indicated only in individual cases, report researchers.

16 Oct 2012

Simulation training can vastly improve trainee surgeons' skills prior to live procedures

In a paper published today in Archives of Otolaryngology-Head & Neck Surgery entitled "Criterion-Based Training to Improve Surgical Performance," researchers at Montefiore Medical Center have demonstrated that current requirements for surgical proficiency, including the performance of a fixed number of surgeries, insufficiently assesses surgical capabilities and does not take into consideration individual learning differences.

16 Oct 2012

Language, ethnicity play a role in postoperative behavioral change among chidlren

A study presented at the ANESTHESIOLOGY 2012 annual meeting found children's negative behavioral change after surgery differs among Spanish- and English-speaking White and Hispanic families.

16 Oct 2012

First Edition: October 16, 2012

Today's early morning highlights from the major news organizations, including reports about a study regarding the possible impact of premium support on Medicare premiums.

16 Oct 2012

Companionship can reduce nerve-related pain

Companionship has the potential to reduce pain linked to nerve damage, according to a new study.

16 Oct 2012

Computerized checklist helps physicians to prevent dangerous venous thromboembolisms or PE

A computerized checklist system designed to help physicians identify and use the best methods of preventing potentially deadly blood clots in hospitalized trauma patients dramatically reduced the number of these dangerous venous thromboembolisms (VTEs), new Johns Hopkins research suggests.

16 Oct 2012

FOS prebiotic could replace intravenous feeding in pediatric patients with intestinal failure

Adding the right prebiotic to the diets of pediatric patients with intestinal failure could replace intravenous feeding, says a new University of Illinois study.

16 Oct 2012

Sterile acellular matrices 'reliable in expander-based breast reconstruction'

Sterile human acellular dermal matrix offers reliable matrix incorporation and a low complication rate for expander-based breast reconstruction, the results of a US study indicate, which also suggest that sterilization does not affect incorporation success.

15 Oct 2012

$Arthroscopy best for scaphoid fracture assessment$

Arthroscopy best for scaphoid fracture assessment

Research shows that radiographs and computed tomography cannot replace arthroscopy for the diagnosis of unstable and displaced fractures of the scaphoid wrist.

15 Oct 2012

Obesity does not affect VTE risk after knee surgery

Being morbidly obese does not increase the risk for developing venous thromboembolism after total knee arthroplasty surgery, report US researchers.

15 Oct 2012

Embryonic neuron transplants could effectively treat brain diseases

The unexpected survival of embryonic neurons transplanted into the brains of newborn mice in a series of experiments at the University of California, San Francisco (UCSF) raises hope for the possibility of using neuronal transplantation to treat diseases like Alzheimer's, epilepsy, Huntington's, Parkinson's and schizophrenia.

15 Oct 2012

Researchers develop two ultra-rapid tests for diagnosis of antibiotic resistance

With their excellent sensitivity and specificity, the use of these extremely efficient tests on a world-wide scale would allow us to adapt antibiotic treatments to the individual's needs and to be more successful in controlling antibiotic resistance, particularly in hospitals.

15 Oct 2012

Few physicians recommend active surveillance for low-risk prostate cancer

Few physicians recommend active surveillance for low-risk prostate cancer rather than pursuing surgery or radiation, according to a Mayo Clinic study being presented at the North Central Section of the American Urological Association's annual meeting Oct. 10-13 in Chicago.

15 Oct 2012

AAPS recognizes top scientists in pharmaceutical sciences

During the Opening Session of the 2012 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition, AAPS President David Y. Mitchell, Ph.D., presented the following ground-breaking researchers with awards commemorating their contributions to the pharmaceutical sciences:

15 Oct 2012

Wal-Mart expanding program for no-cost employee surgeries

Wal-Mart announced this week that it will expand a program that ends out-of-pocket procedure and travel costs for employees seeking some heart and spine surgeries if they go to hospitals across the country that have agreements with the retailer.

15 Oct 2012

Duke researchers develop new 3-D tool for heart surgery

A team of researchers from Duke University speaking at the ANESTHESIOLOGY 2012 annual meeting revealed the development of a new 3-D tool that enables trainees in transesophageal echocardiography (TEE) to have real-time instruction in obtaining and interpreting high-quality images of the heart and major vessels - and it's all just a finger swipe away on your Apple iPad.

15 Oct 2012

Celgene receives FDA approval for ABRAXANE to treat non-small cell lung cancer

Celgene Corporation today announced the U.S. Food and Drug Administration (FDA) has approved ABRAXANE (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) for the first-line treatment of locally advanced or metastatic non-small cell lung cancer, in combination with carboplatin, in patients who are not candidates for curative surgery or radiation therapy.

15 Oct 2012